Control Experimental
A control experimental is any experiment that includes one or more groups or conditions specifically designed to isolate the effect of a single variable by holding all other factors constant. This guide is for students, early career researchers, and life science professionals who need a practical, evidence based framework for designing, executing, and interpreting controlled experiments. You will learn what controls are, how to choose them, a step by step workflow, quality checks, common errors, and the limits of what controls can tell you. All guidance is grounded in authoritative training resources and real published studies from the biomedical and bioinformatics literature NCBI Bookshelf.
At a Glance
| Control Type | Purpose | When to Use |
|---|---|---|
| Negative control | Confirm that no effect occurs when the independent variable is absent | Every experiment that measures a change or outcome |
| Positive control | Confirm that the experimental system can detect an effect when one is present | When validating a new assay, protocol, or reagent |
| Vehicle or sham control | Rule out effects from the delivery method (e.g., solvent, surgery) | Any intervention that involves injection, gavage, implantation, or application of a carrier |
| Time zero or baseline control | Measure the starting state before treatment | Longitudinal studies, time course experiments |
| Internal control | A standard or reference included within each sample (e.g., housekeeping gene) | Quantitative assays like qPCR, RNA seq, western blot |
Core Concepts: What Makes a Control Experimental?
A control experimental is not a single technique, it is a design principle. The central idea is comparison. Without a control group or condition, you cannot attribute an observed outcome to your treatment because alternative explanations (confounders, measurement error, natural variation) remain uncontrolled EMBL EBI Training.
Every experiment has an independent variable (what you manipulate) and a dependent variable (what you measure). Controls are additional groups or conditions that differ from the treatment group only in that they lack the active manipulation. In a drug efficacy study, for example, the negative control group receives a placebo (inactive substance) while the positive control group receives a drug known to work. This structure lets you separate the drug effect from the placebo effect and the assay sensitivity effect.
Published studies frequently illustrate the necessity of controls. In a murine model testing fecal microbiota transplantation to clear antibiotic resistant bacteria, the authors included untreated mice and mice treated with antibiotics alone as controls. Without these, they could not have concluded that the transplantation itself drove the microbiome changes Microbiome changes associated with FMT. Similarly, a rat model of osteoarthritis used intra articular injections of a VEGF inhibitor and compared cartilage degeneration against a sham injected control group. The sham control ruled out damage caused by the injection procedure Intra articular VEGF inhibition.
Controls must be matched to the treatment group on all known confounding variables: age, sex, genetic background, diet, handling, environment, and time of day. For in vitro work, controls should be grown on the same plate, with the same media batch, and processed in the same run. For bioinformatics analyses, controls often take the form of input data from a reference condition or simulated null datasets Galaxy Training Network.
Decision Points: How to Choose the Right Control
Not every experiment needs every type of control, but every experiment needs at least one control that is appropriate for its design. Use these decision criteria to select controls:
What is the research question? If you are testing whether a treatment causes an effect, a negative control is mandatory. If you are testing whether your assay can detect an effect, you need a positive control.
What are the known confounders? For any intervention that involves a vehicle (DMSO, saline, oil) or a physical procedure (injection, surgery, irradiation), include a vehicle or sham control. Without it, you cannot distinguish the treatment effect from the procedural effect.
Is the measurement quantitative and variable? In gene expression or protein abundance studies, include an internal control (housekeeping gene, spike in RNA, total protein normalization) to correct for technical variation across samples Bioconductor.
Is the experiment longitudinal? Include a time zero (baseline) control to measure the starting condition. This allows you to calculate change relative to baseline rather than relying on an external reference.
Does the experiment rely on a new reagent or equipment? Run a positive control first to verify that the system works. For example, in a sequencing run, sequence a known control sample to check library quality and base call accuracy NCBI Sequence Read Archive.
Practical Workflow: Designing and Implementing Controls
Follow this sequence to build controls into any experiment. Adjust the steps to your specific field, but do not skip any.
Step 1: Define the Independent and Dependent Variables
Write down exactly what you will manipulate and what you will measure. For example, in a study of nanoparticle radiosensitizers, the independent variable is the presence or absence of nanoparticles, and the dependent variable is tumor cell survival after radiation Nanoparticle radiosensitizers. This clarity forces you to specify what control conditions are needed.
Step 2: List All Potential Confounders
Brainstorm all factors that could influence the dependent variable besides the independent variable. Common confounders include handling stress, time of day, batch effects, operator skill, and environmental temperature. For each confounder, decide whether to control it by randomization, blocking, or using a control group.
Step 3: Select the Minimum Set of Controls
Use the decision criteria above. For most experiments, a negative control (no treatment or placebo) is required. Add a positive control if the assay is new or if you need to confirm the system's sensitivity. Add a vehicle or sham control if you deliver the treatment through any medium or procedure.
Step 4: Assign Subjects or Samples Randomly
Randomization prevents selection bias. Assign each subject or sample to treatment or control groups using a random number generator. For cell culture or omics experiments, randomize the order of sample processing and data acquisition.
Step 5: Implement Blinding When Possible
Blinding means the person measuring the outcome does not know which group is treatment and which is control. This prevents observer bias. In animal behavior studies, for example, the experimenter who scores video recordings should be blind to group identity. A study on dogs and wolves used double blind procedures to test behavioral reactions to human fear odor, reducing expectation bias Human socialized dogs and wolves.
Step 6: Replicate Controls
Include multiple independent replicates of each control condition. Biological replicates (different subjects or samples) capture natural variation. Technical replicates (same sample measured multiple times) capture measurement error. A control with only one replicate provides no estimate of variability and cannot be used for statistical inference.
Step 7: Document Everything
Record the exact composition of control groups, the randomization scheme, the blinding procedures, and any deviations. Good documentation allows others to reproduce your experiment and assess the validity of your controls.
Quality Checks for Experimental Controls
After you collect data, verify the controls before analyzing the treatment groups. Run these checks:
Check positive controls first. If the positive control did not show the expected effect, the entire experiment may be invalid. Do not proceed until you understand why.
Check negative controls for unexpected signals. A negative control that shows a large effect suggests contamination, measurement error, or a confound. Investigate and repeat if needed.
Check internal controls for consistency. In qPCR, for instance, the Ct values of housekeeping genes should be stable across all samples. High variation indicates poor normalization or RNA degradation.
Assess the magnitude of the control response relative to historical data. If a control that normally shows a small effect suddenly shows a large one, or vice versa, there may be a systemic issue.
Common Mistakes
Omitting the negative control. The most frequent error. Without it, you cannot rule out that the observed effect is due to natural variation, measurement error, or a confound.
Using an inappropriate positive control. A positive control that is too weak or too strong can mislead. For example, using a drug that produces a maximal effect when your assay can only detect subtle changes gives a false sense of sensitivity.
Failing to match control and treatment groups on confounders. If the control group is older, fed differently, or processed on a different day, differences between groups may be due to those factors rather than the treatment.
Not blinding the outcome assessment. Even experienced researchers can unconsciously bias measurements when they know which group is which.
Lack of replication in controls. A single control subject or sample gives no information about variability. You cannot perform a statistical test with one data point.
Analyzing controls separately from the treatment group. Controls are part of the same experiment and should be included in the same statistical model. Treating them as separate experiments reduces power and can lead to false conclusions.
Limits of Interpretation and Uncertainty
Controls are powerful but they do not guarantee that you have identified the true causal mechanism. A control experimental can only rule out the specific confounders you thought to include. Unmeasured confounders remain uncontrolled.
Negative controls can also suffer from issues like contamination or degradation. A negative control that shows a small effect may indicate a real but weak background process, not a failure of the control. Context and prior knowledge are needed to interpret such results.
Positive controls only confirm that the experimental system works under the conditions tested. They do not prove that the treatment effect you observe is real or large. A positive control effect that is much larger than the treatment effect may indicate that your assay is not sensitive enough for the treatment.
In many complex fields like genomics or imaging, controls are not perfect. For example, input controls in ChIP seq experiments (cells that are not treated with antibody) can show nonspecific background that varies between cell types. The choice of control can influence the final list of binding sites. Researchers must validate findings with orthogonal methods.
Statistical interpretation of controls requires care. Comparing treatment to control using a hypothesis test assumes that the control group is an accurate estimate of the null distribution. If the control group is small or poorly replicated, the p value can be unreliable. Always report effect sizes and confidence intervals along with p values.
Frequently Asked Questions
Q: Can I use the same subject as its own control (within subject design)?
A: Yes, but only if the measurement does not permanently alter the subject. For example, measuring blood pressure before and after a drug in the same individual works if the drug washes out completely. This design reduces variability but introduces order effects. Always randomize the order of conditions if possible.
Q: How many control replicates do I need?
A: There is no universal number. In pilot experiments, three biological replicates per group may suffice. For definitive studies, power analysis based on the expected effect size and variability of the control group is recommended. Official training resources from EMBL EBI provide sample size calculators for typical experimental designs EMBL EBI Training.
Q: What if my control group shows a small effect that is statistically significant?
A: Investigate thoroughly. It could be a real biological effect (e.g., the sham procedure itself causes a response) or a technical artifact (e.g., contamination). If the effect is small and consistent, document it and discuss its impact on interpretation. Do not simply discard the control data.
Q: Can I use data from previous experiments as a historical control?
A: Historical controls are sometimes used in late phase clinical trials or long running studies, but they are risky because laboratory conditions, reagents, and subject populations change over time. They cannot replace concurrent controls. In basic research, always include concurrent controls.
References and Further Reading
- NCBI Bookshelf: Experimental Design and Controls , Authoritative text on controlled experimental design in biomedicine.
- Galaxy Training Network: Quality Control , Practical tutorials for implementing quality checks in sequencing experiments.
- Bioconductor: Statistical Methods for Control Groups , Open source software for analyzing control versus treatment comparisons.
- EMBL EBI Training: Statistics for Experimental Design , Free course material on sample size, controls, and randomization.
- NCBI Sequence Read Archive: Control Sample Submission Guidelines , How to submit and retrieve control sequencing data.
- Microbiome changes associated with FMT , Example of proper control use in a murine model.
- Intra articular VEGF inhibition , Sham control in a rat osteoarthritis study.
- Human socialized dogs and wolves , Blinding and behavioral controls in animal cognition.
- Nanoparticle radiosensitizers , Control groups in a nanoparticle radiation study.
- PLK1 inhibition enhances Brentuximab , Positive and negative controls in a lymphoma cell line experiment.